GlassScriptPhysician profile
Dylan Aaron Williams
NPI 1285314690
$1,896.13
in general payments reported to CMS, 2019-2025
21 companies · $810 in 2025
The $810 reported for 2025 was more than what 83% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $243 · 2024: $843 · 2025: $810.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,896.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,896.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $365.83 | 2024-2025 | Impella |
| Novo Nordisk INC | $209.03 | 2024-2025 | Wegovy, Ozempic |
| Kestra Medical Technology Services, INC. | $180.96 | 2025 | Assure Wcd |
| Medtronic, INC. | $158.91 | 2024 | Corevalve Evolut R |
| Novartis Pharmaceuticals Corporation | $157.98 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $131.41 | 2024-2025 | Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $121.82 | 2024-2025 | Lifevest |
| Amgen INC. | $105.13 | 2024-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $72.25 | 2023 | Stingray, Wolverine Coronary Cutting Balloon |
| Astrazeneca Pharmaceuticals LP | $65.96 | 2023-2024 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $62.82 | 2023-2024 | Jardiance |
| Pfizer INC. | $54.93 | 2023-2025 | |
| Inari Medical, INC. | $42.60 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Merck Sharp & Dohme LLC | $36.49 | 2024-2025 | Verquvo |
| Kiniksa Pharmaceuticals International, Plc | $22.11 | 2024 | Arcalyst |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $21.95 | 2024 | Evkeeza |
| Bayer Healthcare Pharmaceuticals INC. | $20.61 | 2023 | |
| Alnylam Pharmaceuticals INC. | $18.85 | 2023 | Onpattro |
| Atricure, INC. | $16.64 | 2023 | |
| Esperion Therapeutics, INC. | $15.44 | 2023 | Nexletol |
| Advanced Oxygen Therapy INC. | $14.41 | 2024 | Topical Oxygen Chamber For Extremities |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dylan Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.